` VICO (Vicore Pharma Holding AB) vs OMX Stockholm 30 Comparison - Alpha Spread

VICO
vs
OMX Stockholm 30

Over the past 12 months, VICO has underperformed OMX Stockholm 30, delivering a return of -56% compared to the OMX Stockholm 30's 6% drop.

Stocks Performance
VICO vs OMX Stockholm 30

Loading

Performance Gap
VICO vs OMX Stockholm 30

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
VICO vs OMX Stockholm 30

Loading
VICO
OMX Stockholm 30
Add Stock

Competitors Performance
Vicore Pharma Holding AB vs Peers

OMX Stockholm 30
VICO
ABBV
AMGN
GILD
VRTX
Add Stock

Vicore Pharma Holding AB
Glance View

Market Cap
1.8B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
HIDDEN
Show
Back to Top